Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2001 | 12-2000 | |
| Gross Profit | N/A | N/A | N/A | 64,020 | 64,900 |
| Operating Expenses | 6,968 | -932 | 1,931 | 0 | 0 |
| Operating Income | -6,968 | 932 | -1,931 | N/A | N/A |
| Other Income | -6,680 | 3,869 | -2,201 | 0 | 0 |
| Pre-tax Income | -13,648 | 4,801 | -4,132 | 0 | 0 |
| Net Income Continuous | -13,648 | 4,801 | -4,132 | N/A | N/A |
| Net Income | $-13,648 | $4,801 | $-4,132 | $N/A | $N/A |
| EPS Basic Total Ops | -24.16 | 1.72 | -24.09 | N/A | N/A |
| EPS Basic Continuous Ops | -24.08 | 1.74 | -23.81 | N/A | N/A |
| EPS Diluted Total Ops | -24.16 | 1.72 | -24.09 | N/A | N/A |
| EPS Diluted Continuous Ops | -24.08 | 1.74 | -23.81 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -24.16 | 1.72 | N/A | N/A | N/A |
| EBITDA(a) | $-6,968 | $932 | $-1,931 | $-110 | $1,780 |